Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4638270
Max Phase: Preclinical
Molecular Formula: C26H35FN4O8
Molecular Weight: 550.58
Molecule Type: Unknown
Associated Items:
ID: ALA4638270
Max Phase: Preclinical
Molecular Formula: C26H35FN4O8
Molecular Weight: 550.58
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COc1c(N2CCN(C)CC2)c(F)cc2c(=O)c(C(=O)N[C@H]3[C@H](O)[C@@H](O)[C@H](CO)[C@H](O)[C@@H]3O)cn(C3CC3)c12
Standard InChI: InChI=1S/C26H35FN4O8/c1-29-5-7-30(8-6-29)19-16(27)9-13-18(25(19)39-2)31(12-3-4-12)10-14(20(13)33)26(38)28-17-23(36)21(34)15(11-32)22(35)24(17)37/h9-10,12,15,17,21-24,32,34-37H,3-8,11H2,1-2H3,(H,28,38)/t15-,17-,21-,22-,23-,24+/m0/s1
Standard InChI Key: JQDJCKJEIIRCGA-NKTPNDDDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 550.58 | Molecular Weight (Monoisotopic): 550.2439 | AlogP: -1.60 | #Rotatable Bonds: 6 |
Polar Surface Area: 167.96 | Molecular Species: NEUTRAL | HBA: 11 | HBD: 6 |
#RO5 Violations: 3 | HBA (Lipinski): 12 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.24 | CX Basic pKa: 6.06 | CX LogP: -2.07 | CX LogD: -2.09 |
Aromatic Rings: 2 | Heavy Atoms: 39 | QED Weighted: 0.25 | Np Likeness Score: -0.09 |
1. Suaifan GARY, Mohammed AAM.. (2019) Fluoroquinolones structural and medicinal developments (2013-2018): Where are we now?, 27 (14): [PMID:31182257] [10.1016/j.bmc.2019.05.038] |
Source(1):